Who is sponsoring NCT02760069?

NCT02760069 is sponsored by Brooke Army Medical Center.

What drugs are being tested in NCT02760069?

Interventions: Inhaled isopropyl alcohol, Oral ondansetron, Inhaled normal saline, Oral placebo.

What is the status of NCT02760069?

NCT02760069 is currently COMPLETED.

Last reviewed 2020-07-12 · How we verify

Nasally Inhaled Isopropyl Alcohol Versus Oral Ondansetron for the Treatment of Nausea in the Emergency Department: A Double-Blind Randomized Controlled Trial

NCT02760069 Phase 4 COMPLETED Results posted

This study will compare the efficacy of isopropyl alcohol and conventional anti-emetics with three study arms: (1) inhaled isopropyl alcohol plus oral ondansetron; (2) inhaled isopropyl alcohol plus oral placebo; (3) inhaled placebo plus oral ondansetron.

Details

Lead sponsor	Brooke Army Medical Center
Phase	Phase 4
Status	COMPLETED
Enrolment	122
Start date	2016-01
Completion	2017-11

Conditions

Nausea

Interventions

Inhaled isopropyl alcohol
Oral ondansetron
Inhaled normal saline
Oral placebo

Primary outcomes

Nausea 100 mm Visual Analogue Scale (VAS) — 30 minutes post intervention
Full Scale Name: Nausea 100-mm visual analogue scale. Scale Construct: Measures nausea as reported by the patient Scale Range: Minimum is 0 (no nausea) to 100 (worst nausea imaginable). These values quantify, on an interval scale anchored at 0, the patient's subjective sensation of nausea. Higher values represent worse outcomes (e.g., more nausea). Patient makes a single vertical mark on a 100 mm horizontal line with 0 at the left and 100 on the right to depict their nausea.

Countries

United States